Who we are
Health biotechnology
Ebiotec is the Euroespes Group's Biotechnology Center where exclusive nutraceutical bioproducts are manufactured for national and international distribution.
The health contributions of nutraceutical products have attracted the attention of medical professionals and human health researchers. The development of active ingredients of natural origin has progressed strongly in recent decades and Ebiotec's vocation for research and innovation has positioned us as one of the leading companies in this field at international level.
Our commitment to society is to put knowledge and biotechnology at the service of people's well-being.
Bioproducts for health
Our nutraceutical bioproducts are developed through a unique non-denaturing biotechnological process, so that they retain all the biological properties of their natural source.
Ebiotec's bioproducts are derived from marine species (LIPOPHYSINS AND PROTEOLIPINS), plant species (FAVALINS), a hybrid line, and an animal line under development.
- 100% natural ingredients that keep all bioactive properties intact.
- 100% Spanish technology and production in the biotechnology plant located in Galicia.
- More than two decades of experience and satisfied consumers.
- Active ingredients derived from marine species (lipophysins and proteolipins) and vegetable species (podofavalins).
- Functionally complex nutraceuticals in which the synergic action of their components increases their efficacy.
- Nutraceuticals with the highest international quality standards.
- Non GMO's, non-irradiated, gluten free, no additives added.
Our services
As pioneers in the area of applied science, we offer innovative services aimed at optimizing human health through the ethical application of the latest scientific advances.
Each Innovation area is designed to identify the latest scientific advances and best available technology to create successful collaborations with both private companies and public scientific entities to develop new bioproducts and nutraceuticals for the consumer.
- Industrial lyophilization.
- Preclinical assays for the functional characterization of bioproducts.
- Development of customized R&D projects.
Our services
As pioneers in the area of applied science, we offer innovative services aimed at optimizing human health through the ethical application of the latest scientific advances.
Each Innovation area is designed to identify the latest scientific advances and best available technology to create successful collaborations with both private companies and public scientific entities to develop new bioproducts and nutraceuticals for the consumer.
- Industrial lyophilization.
- Preclinical assays for the functional characterization of bioproducts.
- Development of customized R&D projects.
Our commitment
Ebiotec is part of the Euroespes Group which, in its 30-year history, has carried out more than 150 research projects, resulting in 1600 scientific publications, several patents and the first World Guide to Pharmacogenomics.
- Genomic medicine applied to risk prediction and early diagnosis of prevalent neurodegenerative and cerebrovascular diseases.
- Pharmacogenomics applied to the personalization of pharmacological treatments.
- Development and production of nutraceutical bioproducts for the prevention and treatment of various pathologies.
- Dissemination of scientific knowledge.
Among our priorities is the search for efficient solutions to the serious problem of dementia (Alzheimer's disease and vascular dementia), stroke and other degenerative problems of the nervous system, such as Parkinson's disease.
All these disabling diseases of the nervous system are the primary target of our preventive and therapeutic programs through the development of vaccines and predictive programs of medical genomics and pharmacogenomics applied to the specific needs of each individual.
EuroEspes health
International Center for Neurosciences and Genomic Medicine EuroEspes
Ebiotec is part of the euroespes group (euroespes health), a pioneer in the worldwide implementation of personalized medicine based on the genetics of each individual.
- Medical Center Specialized in the prevention, early diagnosis and treatment of diseases of the central nervous system (Alzheimer, Parkinson, Dementias), cerebrovascular (stroke), neuropsychiatric (personality disorders, depression, schizophrenia, ...), etc...
- Clinical analysis laboratory (Covid -19, Biopanels, Tumor markers, etc.)
- Predictive genetics: Development of specific panels that assess the genetic risk of developing multiple pathologies.
- Pharmacogenetics: world leaders in the implementation of personalized pharmacogenetics as the most effective pharmacological treatment strategy, avoiding toxic reactions to drugs.
- Health biotechnology: Development of natural bioproducts from research processes and own studies.
